Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1996; 28:1257-1261
© 1996 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Manolis, A.
Right arrow Articles by Cokkinos, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manolis, A.
Right arrow Articles by Cokkinos, D.

Thrombogenicity of radiofrequency lesions: results with serial D-dimer determinations

AS Manolis, H Melita-Manolis, V Vassilikos, T Maounis, J Chiladakis, V Christopoulou-Cokkinou, and DV Cokkinos

Onassis Cardiac Surgery Center, Athens, Greece.

OBJECTIVES: By measuring plasma levels of D-dimer, a product of fibrin degradation, we sought to investigate whether the application of radiofrequency (RF) energy might activate endogenous thrombotic mechanisms. BACKGROUND: Quantitative determination of D-dimer, a bio-chemical marker of thrombus formation and reactive fibrinolysis, helps to diagnose activation of the coagulation system. It remains controversial whether endocardial lesions produced during RF catheter ablation of arrhythmogenic foci have a thrombogenic effect, and the issue of the need for antithrombotic therapy after RF ablation is still unresolved. METHODS: We made serial determinations of plasma D-dimer levels by enzyme immunoassay before insertion of catheters, after completion of electrophysiologic study (EPS) but before RF ablation, immediately after RF ablation and before discharge (at 48 h) from the hospital in 37 patients undergoing RF ablation (22 men, 15 women; mean [+/-SD] age 37 +/- 18 years, range 12 to 74; 16 +/- 16 lesions produced) of accessory (n = 17) or slow (n = 12) pathways, atrial (n = 4) or ventricular foci (n = 3) or the atrioventricular node (n = 1). D-dimer levels were also measured in 26 age-matched control subjects undergoing EPS only. RESULTS: In the RF ablation group, the mean D-dimer levels increased from a baseline value of 29 +/- 28 to 62 +/- 56 micrograms/liter after EPS (p < 0.0001). However, after RF ablation, D-dimer levels increased to much higher levels (188 +/- 138 micrograms/liter, p < 0.0001). There was no correlation of D-dimer levels with the number of RF lesions produced or the duration of the procedure. At 48 h after the procedure, D-dimer levels decreased (75 +/- 67 micrograms/liter) but still remained significantly elevated compared with baseline values (p = 0.0001). Three were no significant differences in baseline (25 +/- 21 micrograms/liter) and post-EPS (51 +/- 50 micrograms/liter) measurements between control subjects and patients. During RF ablation, intravenous heparin was given to nine patients who still demonstrated high plasma D-dimer levels after RF ablation. CONCLUSIONS: As reflected by elevated plasma D-dimer levels, RF ablation has a thrombogenic effect that persists through 48 h after the procedure. This effect needs to be taken into account when considering antithrombotic therapy in patients undergoing RF ablation.


This article has been cited by other articles:


Home page
EuropaceHome page
J. J. Blanc, J. Almendral, M. Brignole, M. Fatemi, K. Gjesdal, E. Gonzalez-Torrecilla, P. Kulakowski, G. Y.H. Lip, D. Shah, C. Wolpert, et al.
Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
Europace, May 1, 2008; 10(5): 513 - 527.
[Full Text] [PDF]


Home page
EuropaceHome page
W. Hochholzer, D. Schlittenhardt, T. Arentz, J. Stockinger, R. Weber, G. Burkle, D. Kalusche, D. Trenk, and F.-J. Neumann
Platelet activation and myocardial necrosis in patients undergoing radiofrequency and cryoablation of isthmus-dependent atrial flutter
Europace, July 1, 2007; 9(7): 490 - 495.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
S. Carasso, R. Kuperstein, E. Konen, M. Glikson, and M. S. Feinberg
Plowing the atrium and growing thrombi: Two cases of large atrial thrombi following ablative and surgical procedure for atrial fibrillation
Eur J Echocardiogr, October 1, 2006; 7(5): 383 - 386.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. F. Scholten, A. S. Thornton, J. M. Mekel, P. J. Koudstaal, and L. J. Jordaens
Anticoagulation in atrial fibrillation and flutter
Europace, January 1, 2005; 7(5): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Khairy, P. Chauvet, J. Lehmann, J. Lambert, L. Macle, J.-F. Tanguay, M. G. Sirois, D. Santoianni, and M. Dubuc
Lower Incidence of Thrombus Formation With Cryoenergy Versus Radiofrequency Catheter Ablation
Circulation, April 22, 2003; 107(15): 2045 - 2050.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
D. S. Y. Lee, P. Dorian, E. Downar, M. Burns, E. L. Yeo, W. L. Gold, M. Paquette, W. Lau, and D. M. Newman
Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation?
Europace, January 1, 2001; 3(3): 195 - 200.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Nitta, Y. Ishii, H. Ogasawara, S. Sakamoto, Y. Miyagi, K. Yamada, S. Kanno, and S. Tanaka
Initial experience with the radial incision approach for atrial fibrillation
Ann. Thorac. Surg., September 1, 1999; 68(3): 805 - 810.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. L. Ware, P. Boor, C. Yang, A. Gowda, J. J. Grady, and M. Motamedi
Slow Intramural Heating With Diffused Laser Light : A Unique Method for Deep Myocardial Coagulation
Circulation, March 30, 1999; 99(12): 1630 - 1636.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement